[Changes in transfusion practice for surgery].
The context of transfusion has changed in recent years. Some data could lead to an increased demand: the risk of viral transmission has significantly decreased; a national survey has revealed that the mortality related to an insufficient or delayed transfusion was higher to the side effects of the transfusion itself. Some other data could decrease the demand: the preoperative use of EPO is now easier; the intraoperative use of antifibrinolytic has been shown to be efficient. The number of allogenic red blood cells units (RBCs) transfused each year in France regularly increases, while the transfusion of predeposited autologous blood is in sharp decline. However, in hospitals still using but reducing this technique, the consumption of allogenic RBCs does not increase and the transfusion of any blood (allogenic and/or autologous) decreases. The strategy is based on preoperative evaluation of usual blood loss and tolerable blood loss by accepting a reasonable risk of allogenic blood transfusion. Advances in public health seem to be found above all in the analysis of system failures.
Lienhart
A
A
Service d'anesthésie-réanimation, hôpital Saint-Antoine, 184 rue du Faubourg-Saint-Antoine, Paris, France. andre.lienhart@sat.aphp.fr
D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001803:Blood Transfusion / Q000639:trends*; D001804:Blood Transfusion, Autologous; D006801:Humans; D011300:Preoperative Care; D013514:Surgical Procedures, Operative / Q000639:trends*